These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28796564)

  • 1. Factors influencing the economics of biosimilars in the US.
    Mehr SR; Brook RA
    J Med Econ; 2017 Dec; 20(12):1268-1271. PubMed ID: 28796564
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosimilars take center stage.
    Adams KT
    Manag Care; 2014 Apr; 23(4):44-6. PubMed ID: 24864533
    [No Abstract]   [Full Text] [Related]  

  • 3. Competition in the Age of Biosimilars.
    Chandra A; Vanderpuye-Orgle J
    JAMA; 2015 Jul; 314(3):225-6. PubMed ID: 26197179
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosimilars and the European experience: implications for the United States.
    Megerlin F; Lopert R; Taymor K; Trouvin JH
    Health Aff (Millwood); 2013 Oct; 32(10):1803-10. PubMed ID: 24101072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare Advantage.
    Karaca-Mandic P; Chang J; Go R; Schondelmeyer S; Weisdorf D; Jeffery MM
    Health Aff (Millwood); 2019 Nov; 38(11):1887-1892. PubMed ID: 31682491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA issues guidelines for biosimilar drugs.
    Cancer Discov; 2012 Mar; 2(3):196. PubMed ID: 22585973
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosimilars: Implications for Clinical Practice.
    Rifkin RM; Peck SR
    J Oncol Pract; 2017 Sep; 13(9_suppl):24s-31s. PubMed ID: 28898593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders discuss biosimilar naming, substitution.
    Traynor K
    Am J Health Syst Pharm; 2014 Mar; 71(6):446-7. PubMed ID: 24589534
    [No Abstract]   [Full Text] [Related]  

  • 9. First biosimilar drug approved for sale in the United States.
    Hede K
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142444
    [No Abstract]   [Full Text] [Related]  

  • 10. Biosimilar competition in the United States: statutory incentives, payers, and pharmacy benefit managers.
    Falit BP; Singh SC; Brennan TA
    Health Aff (Millwood); 2015 Feb; 34(2):294-301. PubMed ID: 25646110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosimilars Charge the Market But Still Face Many Hurdles.
    Reinke T
    Manag Care; 2015 Apr; 24(4):16-7. PubMed ID: 26489169
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosimilars: biologics that meet patients' needs and healthcare economics.
    McCamish M; Yoon W; McKay J
    Am J Manag Care; 2016 Sep; 22(13 Suppl):S439-S442. PubMed ID: 28719221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biosimilar Pipeline Seams Seem To Be Bursting.
    Reinke T
    Manag Care; 2017 Mar; 26(3):24-25. PubMed ID: 28510516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tildrakizumab-asmn: What's in a Name?
    Yang EJ; Beck KM; Liao W
    Am J Clin Dermatol; 2018 Jun; 19(3):291-292. PubMed ID: 29687361
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosimilars.
    Bagel J
    J Drugs Dermatol; 2014 Jul; 13(7):788-90. PubMed ID: 25007360
    [No Abstract]   [Full Text] [Related]  

  • 16. The emerging role of biosimilar epoetins in nephrology in the United States.
    Fishbane S; Shah HH
    Am J Kidney Dis; 2015 Apr; 65(4):537-42. PubMed ID: 25582283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosimilars: where we were and where we are.
    Challand R; Gorham H; Constant J
    J Biopharm Stat; 2014; 24(6):1154-64. PubMed ID: 25036475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosimilars Ready, At Last, To Make Their Entrance: Stars Are Born or Do They Fizzle?
    Reinke T
    Manag Care; 2017 Mar; 26(3):20-23. PubMed ID: 28510515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosimilars might not measure up to health plan expectations.
    Reinke T
    Manag Care; 2012 Oct; 21(10):12-3. PubMed ID: 23156071
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech innovators jump on biosimilars bandwagon.
    Moran N
    Nat Biotechnol; 2012 Apr; 30(4):297-9. PubMed ID: 22491261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.